Clinical trials recruiting in Kitakyusyu-shi, Japan

Phase breakdown

Conditions recruiting in Kitakyusyu-shi, Japan

Recruiting trials in Kitakyusyu-shi, Japan

• A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
  NCT07761117 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
  NCT07684144 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
  NCT06307652 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Kitakyusyu-shi, Japan?

3 recruiting trials have at least one study site in Kitakyusyu-shi, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.